Clinical and economic significance of consistent iron substitution in recombinant human erythropoietin therapy of anaemia in haemodialysis patients

Abstract

Anemia is common in hemodialysis patients. Efficacy of recombinant erythropoietin depends on the bioavailability of iron.

We observed the effect of iron supplementation on a consistent hematocrit and erythropoietin dose. Economic savings due to reduced erythropoietin need is 20 times greater than the cost of increased iron supplementation.

Keywords

• Clinical
• Economical
• Significance
• Consistent
• Replacement
• Recombinant
• Human
• Erythropoietin
• Treatment
• Anaemia
• Patients
• Hemodialysis